Directory
>
Nina Kola
Nina Kola
Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology | Bristol Myers Squibb
Pennington, New Jersey, United States
Nina Kola
Summary
Nina Kola is an accomplished executive in the pharmaceutical industry, currently serving as the Vice President and Therapeutic Area Head for Medical Safety Assessment in Hematology and Oncology at Bristol Myers Squibb. With a robust background in medical safety assessment and pharmacovigilance, Nina has held various leadership positions at Bristol Myers Squibb, demonstrating a strong commitment to patient safety and innovative treatment solutions. Her extensive experience spans over 15 years in the pharmaceutical sector, including roles at Amgen and Takeda. Nina's strategic vision and leadership have significantly contributed to the advancement of medical safety practices within her organizations. She is known for her ability to navigate complex regulatory landscapes and foster collaborative relationships across multidisciplinary teams. Nina is passionate about driving advancements in oncology therapies and improving patient outcomes through rigorous safety assessments. Her journey reflects a dedication to bridging science and patient care, making her a respected leader in her field.
Nina Kola
Work Experience
Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology at
Bristol Myers Squibb
August 2024 - Present
Vice President, Head Medical Safety Assessment Oncology at
Bristol Myers Squibb
January 2024 - August 2024
Vice President, Head Medical Safety Assessment Cardiovascular and Mature Products at
Bristol Myers Squibb
July 2022 - January 2024
Executive Director, Medical Safety Assessment Therapeutic Area Lead, Solid Tumor Oncology at
Bristol Myers Squibb
September 2020 - July 2022
Group Medical Director, Medical Safety Assessment Therapeutic Area Lead, Solid Tumor Oncology at
BRISTOL MYERS SQUIBB FARMACEUTICA
February 2020 - September 2020
Medical Director, Medical Safety Assessment Physician, Immuno-Oncology at
Bristol Myers Squibb
February 2015 - February 2020
Global Safety Director at
Amgen, Inc.
February 2013 - November 2014
Medical Director, Pharmacovigilance at
TAKEDA DEVELOPMENT CENTRE EUROPE LTD.
August 2011 - January 2013
Associate Medical Director, Pharmacovigilance at
Takeda Pharmaceuticals America, Inc.
June 2009 - September 2011
Medical Adviser then Senior Patient Safety Physician at
Pfizer, Inc.
January 2005 - January 2009
Frequently Asked Questions about Nina Kola
What is Nina Kola email address?
Nina Kola's primary email address is ******@tgrd.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Nina Kola work for?
Nina Kola is a Vice President, Medical Safety Assessment Therapeutic Area Head, Hematology and Oncology at Bristol Myers Squibb, a company specializing in Biological products, except diagnostic.
How can I directly contact Nina Kola?
To contact Nina Kola directly, you can use the email address ******@tgrd.com. Complete contact information is available upon registration with Muraena.
Who is Nina Kola?
Nina Kola is an accomplished executive in the pharmaceutical industry, currently serving as the Vice President and Therapeutic Area Head for Medical Safety Assessment in Hematology and Oncology at Bristol Myers Squibb. With a robust background in medical safety assessment and pharmacovigilance, Nina has held various leadership positions at Bristol Myers Squibb, demonstrating a strong commitment to patient safety and innovative treatment solutions. Her extensive experience spans over 15 years in the pharmaceutical sector, including roles at Amgen and Takeda. Nina's strategic vision and leadership have significantly contributed to the advancement of medical safety practices within her organizations. She is known for her ability to navigate complex regulatory landscapes and foster collaborative relationships across multidisciplinary teams. Nina is passionate about driving advancements in oncology therapies and improving patient outcomes through rigorous safety assessments. Her journey reflects a dedication to bridging science and patient care, making her a respected leader in her field.
Nina`s contact details
******@tgrd.com
*********@bms.com
Colleagues
Vice President Informatics & Predictive Sciences at Bristol Myers Squibb
Executive Director, US Hematology Marketing
Executive Director, Clinical Data Acquisition
Vice President, Head of Worldwide Commercialization Strategy & Operations
Vice President, Cell Therapy Commercial Organization
VP External Manufacturing Biologics
Associate Director, Commercial Data Science & Decision Analytics
Executive Director Head of Clinical Evaluation and Collaborations, Immunology and Fibrosis
Executive Director, Digital Health TA Lead - Cardiovascular and Neuroscience
VP, US Commercialization Analytics